Product Information

VORICONAZOLE 200 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $2.0640 per EA under NDC 68462057330. Its NADAC has been published 561 times since Feb 24, 2016.

FDA first approved this application on Sep 2, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VORICONAZOLE 200 MG TABLET

voriconazole
$2.0640per EA

Strength

200 mg/1

NDC

68462057330

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

VORICONAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA203503

FDA Approved

9/2/2015

TE Code

AB

On Market Since

9/4/2015

Pharmacological Classes

Azole Antifungal
Azoles
Cytochrome P450 2C19 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for VORICONAZOLE 200 MG TABLET has been published 561 times since Feb 24, 2016, and over the history we have for it it has declined 87.0%. The table below summarizes its recorded NADAC range and movement.

Current price$2.0640 per EA
All-time high$16.5527 (Jul 13, 2016)
All-time low$1.3268 (Sep 20, 2023)
52-week high$2.2348
52-week low$1.7468
Median price$3.3643
Average price$4.7434
Largest weekly change-61.5% (Jun 23, 2021)
Weeks tracked561
Tracking sinceFeb 24, 2016

Price History

1W

+0.7%

1M

+9.5%

3M

+14.6%

6M

-7.4%

1Y

+7.3%

3Y

+5.1%

5Y

-10.8%

All

-87.0%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VORICONAZOLE 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VORICONAZOLE 200 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $2.0640 per EA (NDC 68462057330), effective Nov 18, 2026.

How has the price of VORICONAZOLE 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for VORICONAZOLE 200 MG TABLET has declined 87.0%. It has been tracked across 561 weekly CMS publications since Feb 24, 2016.

What are the highest and lowest recorded NADAC prices for VORICONAZOLE 200 MG TABLET?

Since Feb 24, 2016, the NADAC for VORICONAZOLE 200 MG TABLET has ranged from a low of $1.3268 (Sep 20, 2023) to a high of $16.5527 (Jul 13, 2016), with a median of $3.3643 per EA.

Are there cheaper alternatives to VORICONAZOLE 200 MG TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VORICONAZOLE 200 MG TABLET, is $1.5586 per EA — about 24% below VORICONAZOLE 200 MG TABLET.

Who manufactures VORICONAZOLE 200 MG TABLET?

VORICONAZOLE 200 MG TABLET (NDC 68462057330) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.